Question 1

What specific types of solid tumors are eligible for this trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the First in Human Study of QLS5316 in Solid Tumors clinical trial (NCT07358884). Contact the study team or your healthcare provider for specific answers.

Question 2

How does QLS5316 compare to my current treatment options?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the First in Human Study of QLS5316 in Solid Tumors clinical trial (NCT07358884). Contact the study team or your healthcare provider for specific answers.

Question 3

What are the potential side effects of QLS5316?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the First in Human Study of QLS5316 in Solid Tumors clinical trial (NCT07358884). Contact the study team or your healthcare provider for specific answers.

Question 4

How often will I need to come in for visits during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the First in Human Study of QLS5316 in Solid Tumors clinical trial (NCT07358884). Contact the study team or your healthcare provider for specific answers.

Question 5

What tests will I need to undergo while participating in this study?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the First in Human Study of QLS5316 in Solid Tumors clinical trial (NCT07358884). Contact the study team or your healthcare provider for specific answers.

Question 6

How will my health be monitored throughout the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the First in Human Study of QLS5316 in Solid Tumors clinical trial (NCT07358884). Contact the study team or your healthcare provider for specific answers.

What this study is about